25 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Showing 25 of 25 clinical reviews.
Does alprostadil (Caverject, MUSE) affect appetite or food cravings? A physician-reviewed deep dive into the pharmacology, clinical trial data, and patient reporting around alprostadil and appetite changes.
A physician-level review of alprostadil pharmacology, efficacy, and safety in patients with autoimmune conditions including lupus, rheumatoid arthritis, Sjogren syndrome, and vasculitis. Includes dosing, contraindications, and clinical decision guidance.
A physician-reviewed analysis of alprostadil's effects on bone metabolism, density, and fracture risk in men with erectile dysfunction, with primary-literature citations and clinical guidance.
A clinician-level review of the available pharmacovigilance data, mechanistic arguments, and primary literature on whether alprostadil (Caverject, MUSE) carries a meaningful cancer risk signal for men using it to treat erectile dysfunction.
A clinician-level review of alprostadil's long-term cardiovascular effects, hemodynamic profile, safety data, and prescribing considerations for men with erectile dysfunction and concurrent cardiac disease.
A clinician-level review of alprostadil's effects on cognitive function, covering prostaglandin E1 neurophysiology, evidence from ED and cerebrovascular trials, dosing, and what patients should realistically expect.
A physician-reviewed comparison of compounded alprostadil versus branded Caverject and MUSE for refractory erectile dysfunction, covering efficacy, safety, cost, regulatory status, and how to choose the right formulation.
A GRADE-graded review of alprostadil (Caverject, MUSE) for refractory erectile dysfunction: key trials, mechanism, dosing, safety, and clinical decision-making at PharmD/MD depth.
A physician-reviewed guide to the dermatologic effects of alprostadil injection and suppository therapy, including hair changes, skin reactions, and clinical management strategies.
A physician-level review of whether alprostadil (Caverject, MUSE) affects liver function, including pharmacokinetic data, clinical trial evidence, and dosing guidance for patients with hepatic impairment.
A physician-level review of how alprostadil affects mental health and mood in men with erectile dysfunction, covering psychogenic ED, anxiety, relationship quality, and clinical trial data.
A physician-level review of how alprostadil is absorbed, distributed, metabolized, and eliminated, plus its documented effects on local and systemic energy expenditure. Includes dosing, pharmacokinetics, and clinical trial data.
A clinician-level review of alprostadil microdosing protocols for erectile dysfunction, covering intracavernosal and intraurethral dose titration, combination regimens, and the primary-literature evidence base for sub-standard dosing strategies.
A clinician-level guide to alprostadil muscle preservation strategies for patients using Caverject or MUSE, covering injection technique, fibrosis prevention, dose titration, and long-term penile tissue health based on primary literature.
A clinician-level guide to diagnosing and correcting alprostadil plateau and non-response in men with refractory erectile dysfunction, including dose optimization, combination strategies, and when to escalate care.
A clinician-level review of alprostadil (Caverject, MUSE) for erectile dysfunction after bariatric surgery, covering pharmacology, dosing adjustments, efficacy data, and practical management considerations.
A clinician-level guide to managing alprostadil hold windows before surgery, covering pharmacokinetics, priapism risk, anesthesia interactions, and evidence-based perioperative protocols.
Does stopping alprostadil cause rebound ED or withdrawal? A physician-reviewed, evidence-based guide covering what happens physiologically when you discontinue Caverject injections or MUSE suppositories, with primary-literature citations.
A clinician-level guide to how temperature, humidity, travel, and seasonal vascular changes affect alprostadil (Caverject/MUSE) storage, dosing, and efficacy in men with refractory erectile dysfunction.
A physician-reviewed deep dive into how alprostadil (Caverject, MUSE) affects erectile and sexual function, covering mechanism, clinical trial data, dosing, and patient selection for refractory ED.
Does alprostadil affect sleep architecture? A clinical deep-dive into how intracavernosal and intraurethral alprostadil interact with nocturnal penile tumescence, prostaglandin-mediated sleep pathways, and what that means for men using Caverject or MUSE.
MD/PharmD-level guide to traveling with alprostadil injections and suppositories: storage during flights, timezone dosing adjustments, TSA rules, cold-chain recovery, and clinical protocols for men using Caverject or MUSE away from home.
A physician-level review of alprostadil's effects on renal hemodynamics, renal protection data, nephrotoxicity risk, and clinical guidance for patients with CKD or renal impairment using Caverject or MUSE.
A physician-level guide to safely restarting alprostadil (Caverject intracavernosal injection or MUSE intraurethral suppository) after hospitalization, surgery, cardiovascular events, or other acute illness, with dosing protocols and monitoring criteria.
A physician-reviewed, week-by-week guide to alprostadil (Caverject/MUSE) for erectile dysfunction: dosing, expected responses, side effects, and clinical benchmarks drawn from primary literature.